- Home
- PCYO vs STXS Comparison
PCYO vs STXS Comparison
Compare PCYO & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- STXS
- Stock Information
- Founded
- PCYO 1976
- STXS 1990
- Country
- PCYO United States
- STXS United States
- Employees
- PCYO N/A
- STXS N/A
- Industry
- PCYO Water Supply
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PCYO Utilities
- STXS Health Care
- Exchange
- PCYO Nasdaq
- STXS Nasdaq
- Market Cap
- PCYO 267.7M
- STXS 275.9M
- IPO Year
- PCYO N/A
- STXS 2004
- Fundamental
- Price
- PCYO $11.01
- STXS $2.91
- Analyst Decision
- PCYO
- STXS
- Analyst Count
- PCYO 0
- STXS 0
- Target Price
- PCYO N/A
- STXS N/A
- AVG Volume (30 Days)
- PCYO 63.2K
- STXS 539.8K
- Earning Date
- PCYO 11-13-2025
- STXS 11-11-2025
- Dividend Yield
- PCYO N/A
- STXS N/A
- EPS Growth
- PCYO 123.89
- STXS N/A
- EPS
- PCYO 0.56
- STXS N/A
- Revenue
- PCYO $27,447,000.00
- STXS $31,806,000.00
- Revenue This Year
- PCYO N/A
- STXS $30.98
- Revenue Next Year
- PCYO N/A
- STXS $49.86
- P/E Ratio
- PCYO $19.66
- STXS N/A
- Revenue Growth
- PCYO 40.36
- STXS 33.94
- 52 Week Low
- PCYO $9.65
- STXS $1.54
- 52 Week High
- PCYO $14.63
- STXS $3.59
- Technical
- Relative Strength Index (RSI)
- PCYO 51.74
- STXS 43.91
- Support Level
- PCYO $10.90
- STXS $2.95
- Resistance Level
- PCYO $11.11
- STXS $3.15
- Average True Range (ATR)
- PCYO 0.15
- STXS 0.13
- MACD
- PCYO -0.01
- STXS -0.03
- Stochastic Oscillator
- PCYO 50.00
- STXS 6.37
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.